A Real-World Precision Medicine Program Including the KidneyIntelX Test Effectively Changes Management Decisions and Outcomes for Patients With Early-Stage Diabetic Kidney Disease.
Joji TokitaDavid LamAida VegaStephanie WangLeonard AmorusoTamara MullerNidhi NaikShivani RathiSharlene MartinAzadeh ZabetianCatherine LiuCatherine SinfieldTony McNicholasFergus FlemingSteven G CocaGirish N NadkarniRoger TunMike KattanMichael J DonovanArshad K RahimPublished in: Journal of primary care & community health (2024)
Deployment and risk stratification by KidneyIntelX was associated with an escalation in action taken to optimize cardio-kidney-metabolic health including medications and specialist referrals. Glycemic control and kidney function trajectories improved post-KidneyIntelX testing, with the greatest improvements observed in those scored as high-risk.
Keyphrases
- glycemic control
- type diabetes
- early stage
- blood glucose
- public health
- healthcare
- palliative care
- weight loss
- quality improvement
- depressive symptoms
- insulin resistance
- mental health
- open label
- health information
- wound healing
- clinical trial
- adipose tissue
- metabolic syndrome
- risk assessment
- social media
- neoadjuvant chemotherapy
- locally advanced